Abstract Intratumoral heterogeneity (ITH) – cellular and molecular diversity within a tumor is linked to failure of immunotherapy in multiple cancer types. A high degree ITH associated with poor infiltration T cells into the resistance immune checkpoint blockade (ICB) therapy. To determine how distinct populations heterogeneous tumors shape microenvironment this impacts therapy response, we mod...